Cite
HARVARD Citation
Cheng, S. et al. (2013). Breast cancer‐derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet‐derived growth factor receptor signaling. FEBS letters. 587 (20), pp. 3289-3295. [Online].